2017年4月25日，澳大利亞中國西南部企業(yè)家協(xié)會(huì )聯(lián)合重慶中世聯(lián)合文化傳媒有限公司主辦的中澳多克隆抗體"TS技術(shù)"生物醫藥國際交流合作圓滿(mǎn)落幕!為期兩天的洽談合作行程安排充實(shí)而緊湊，內容完善且富有建設性，而多克隆抗體"TS技術(shù)"的核心技術(shù)介紹和高端動(dòng)物藥常山酮宏大市場(chǎng)前景，以及重慶威鵬藥業(yè)和澳大利亞阿爾法歐米伽生物科技有限公司的醫藥國際合作對接點(diǎn)成為此次交流合作關(guān)注的首要焦點(diǎn)。

April 25th, 2017, China-Australia Biomedical Exchanges and Cooperation on “TS Technology” Producing Polyclonal Antibody hosted by Chongqing Sino-World Culture Media Co.,Ltd. , the subordinate company of the Australian Entrepreneurs Association of Southwestern China was rounded off! The two day’s agenda is by no means only substantial but perfect as well. Furthermore, both “TS Technology” producing polyclonal antibody and Halofuginone used to produce high-end animal drugs have potential market. The docking of Alpha Omega BIOSCIENCE CORPORATION PTY LTD and the Chongqing Vpon Pharmaceutical Co.,Ltd. attracts great attention.

2017年4月24日下午，澳大利亞中國西南部企業(yè)家協(xié)會(huì )執行會(huì )長(cháng)游尊偉先生，協(xié)會(huì )海外會(huì )長(cháng)Scott Mitchell，副會(huì )長(cháng)兼理事何勇林先生等受邀攜澳大利亞阿爾法歐米伽生物科學(xué)有限公司商業(yè)總監Ben Bootle，經(jīng)理Chris Caroutas，科研顧問(wèn)Sock Hwee Tan，重慶西部物流園代表及商界傳媒記者代表等考察團前往重慶威鵬藥業(yè)南川基地考察交流。

Invited by the Chongqing Vpon Pharmaceutical Co.,Ltd. , a delegation consisting of Mr Zunwei You, the Executive President of the Association; Scott Mitchell, the Overseas Chairman of the Association; Mr Allen He, the President and Supervisor Of the Association and Chris Caroutas, the Director of the Alpha Omega BIOSCIENCE CORPORATION PTY LTD; Ben Bootle, the Commercial Director of the Alpha Omega BIOSCIENCE CORPORATION PTY LTD; Sock Hwee Tan, the Consultant of the the AlphaOmega BIOSCIENCE CORPORATION PTY LTD and representative form the Management Committee in Chongqing Western Logistics Park; reporter from the Biz Media Group and so on visited the base of the Chongqing Vpon Pharmaceutical Co.,Ltd. in Nanchuan.

鵬藥業(yè)董事長(cháng)林國躍先生對考察團一行的到訪(fǎng)表示熱烈歡迎，引領(lǐng)參觀(guān)園區廠(chǎng)房。威鵬執行副總胡莎博士詳細介紹了廠(chǎng)房的基建工程以及使用狀況。廠(chǎng)區規模宏大，設計合理，結構完整。胡莎博士表示目前廠(chǎng)區基礎建設已基本完成，投資到位5個(gè)月后，即可開(kāi)始試生產(chǎn)。同時(shí)，胡莎博士就威鵬藥業(yè)的管理團隊，科研團隊，主營(yíng)產(chǎn)品，融資計劃，發(fā)展前景等做了國際醫療行業(yè)的相關(guān)介紹。

Mr Lin Guoyue, the Chairman of the Chongqing Vpon Pharmaceutical Co.,Ltd. extended his warmest welcome to the delegation, guiding them to visit the factory. Doctor Hu Sha, the Executive Vice President, further explained the construction and usage of the factory, which has a large scale, reasonable designing and perfect structure. Doctor Hu said that the factory, almost completed, can be used for production within 5 months after gaining the investment. Doctor Hu further introduced the company, in terms of management team, research team, major products, financing plan and development prospects.

隨后，威鵬團隊攜考察團一行拜訪(fǎng)了重慶市南川工業(yè)園區管理委員會(huì )。重慶市南川區委常委、統戰部長(cháng)、工業(yè)園區黨工委書(shū)記毛朝銀先生對考察團一行表示熱烈歡迎，對重慶威鵬藥業(yè)有限公司與澳大利亞阿爾法歐米伽生物科技有限公司的國際醫療行業(yè)領(lǐng)先的創(chuàng )新合作高度重視，贊同中澳國際項目合作落地南川工業(yè)園區。同時(shí)重慶南川區府會(huì )也會(huì )積極協(xié)助國際發(fā)展，促進(jìn)國際經(jīng)濟、文化交流。

Later, representatives from the Chongqing Vpon Pharmaceutical Co.,Ltd. accompanied the delegation to visit the Management Committee of Chongqing Nanchuan Industry Park. Mr Mao Chaoyin, the member of the standing committee of Nanchuan District, head of the United Front Work Department extended his warmest regards to the delegation; attached great importance to the innovative, advanced, international and medical cooperation between the Alpha Omega BIOSCIENCE CORPORATION PTY LTD and the Chongqing Vpon Pharmaceutical Co.,Ltd. and appreciated that the international cooperation between China and Australia can put into operation in Nanchuan Industry Park. Meanwhile, the government of Nanchuan will fully support such international cooperation, promoting international economy and cultural exchange.

最后，考察團一行于南川工業(yè)園區管理委員會(huì )大廳前合影留念。重慶威鵬藥業(yè)安排了豐盛晚宴，游尊偉會(huì )長(cháng)代表協(xié)會(huì )和澳大利亞代阿爾法有限公司代表對威鵬藥業(yè)的盛情款待表示感謝，十分期待與威鵬藥業(yè)的深度合作。

At last, the delegation took a photo in front of the lobby of the Management Committee of Chongqing Nanchuan Industry Park. Then the Chongqing Vpon Pharmaceutical Co.,Ltd. held a reception dinner for the delegation. Both Mr You and representatives from the Alpha Omega BIOSCIENCE CORPORATION PTY LTD extended their thanks, looking forward to a deeper cooperation.

2017年4月25日上午中澳多克隆抗體"TS技術(shù)"生物醫學(xué)合作交流會(huì )于在重慶兩江新區復地復城國際16樓正式拉開(kāi)序幕。

April 25th, 2017, The conference "China-Australia Biomedical Exchanges and Cooperation on “TS Technology” Producing Polyclonal Antibody "hold 16th Floor Forte Complex City, NO.7 Longjing Road, Liangjiang New Area,Chongqing,China.

澳大利亞中國西南部企業(yè)家協(xié)會(huì )執行會(huì )長(cháng)游尊偉先生，海外會(huì )長(cháng)Scott Mitchell，會(huì )長(cháng)兼監事何勇林先生，綜合部經(jīng)理李香等，澳大利亞阿爾法歐米伽生物科學(xué)有限公司商業(yè)總監Ben Bootle，經(jīng)理Chris Caroutas，公司顧問(wèn)Sock Hwee Tan，重慶威鵬藥業(yè)有限公司董事長(cháng)林國躍先生，執行總裁林松先生，執行副總胡莎博士，研發(fā)總監周興國先生等，重慶西部現代物流園管理委員會(huì )戰略運營(yíng)中心總監王渝培先生等及商界傳媒記者等出席了此次會(huì )議。

The participating guests were as followed:Mr Zunwei You, the Executive President of the Association; Scott Mitchell, the Overseas Chairman of the Association; Mr Allen He, the President and Supervisor Of the Association;Jessica Lee,the Manager of Comprehensive Department of the Association and Mr,Guoyue Lin,the Chairman of the Chongqing Vpon Pharmaceutical Co.,Ltd.Mr.Song Lin,Chief Executive Officer of the Chongqing Vpon Pharmaceutical Co.,Ltd.Dr.Hu,Executive Vice President of the Chongqing Vpon Pharmaceutical Co.,Ltd.and Chris Caroutas, the Director of the Alpha Omega BIOSCIENCE CORPORATION PTY LTD; Ben Bootle, the Commercial Director of the Alpha Omega BIOSCIENCE CORPORATION PTY LTD; Sock Hwee Tan, the Consultant of the the AlphaOmega BIOSCIENCE CORPORATION PTY LTD and representative form the Management Committee in Chongqing Western Logistics Park; reporter from the Biz Media Group and so on

澳大利亞中國西南部企業(yè)家協(xié)會(huì )綜合部經(jīng)理李香女士宣布會(huì )議開(kāi)始，熱烈歡迎嘉賓的到來(lái)，對參會(huì )人員進(jìn)行介紹并提出本次洽談會(huì )主要探討內容。

Jessica Lee, the assistant of comprehensive department of the Australian Entrepreneurs Association of Southwestern China welcomed the arrival of the guests, introduced the participants and presented the main discussion of the content of this conference.

澳大利亞中國西南部企業(yè)家協(xié)會(huì )執行會(huì )長(cháng)游尊偉先生為會(huì )議致辭，會(huì )長(cháng)兼監事何勇林先生向與會(huì )嘉賓就協(xié)會(huì )的發(fā)展戰略，工作方向作了詳細介紹和討論，協(xié)會(huì )專(zhuān)業(yè)國際橋梁平臺的架構和職能得到了與會(huì )嘉賓的一致肯定與高度認可。

Mr Zunwei You, the Executive President of the Association addressed his opening speech.the President and supervisor of the association Mr He expressed detailly about the aims,direction and structure of the association which was highly approved by the participating guests.

隨后，澳大利亞阿爾法歐米伽生物科學(xué)有限公司科研顧問(wèn)Sock Hwee Tan就公司核心科研技術(shù)("TS技術(shù)")進(jìn)行了介紹。她介紹到TS技術(shù)的優(yōu)勢能夠在短時(shí)間內生產(chǎn)高質(zhì)量，強大的抗體，也大大降低了制造工藝成本。在生產(chǎn)過(guò)程中，這個(gè)顯著(zhù)的技術(shù)變革為當前行業(yè)提供了巨大的價(jià)值主張。

Then, Sock Hwee Tan, the research consultant at AlphaOmega BIOSCIENCE CORPORATION PTY LTD , introduced "TS Technology". She introduced the advantages of TS technology to produce high quality, powerful antibodies in a short time, but also greatly reduced the cost of manufacturing processes. In the process, this significant technological changed for the current industry to provide a great value proposition.

隨后，重慶威鵬藥業(yè)有限公司胡莎博士就高端動(dòng)物藥常山酮技術(shù)在質(zhì)量檢測、研發(fā)技術(shù)、市場(chǎng)前景等方面進(jìn)行了深層次的講解。威鵬藥業(yè)科研團隊鍥而不舍的科研精神令人敬佩，科研專(zhuān)利碩果矚目。之后雙方專(zhuān)家就常山酮技術(shù)和"TS技術(shù)"的國際合作細節進(jìn)行了自由答疑和深入探討，氛圍友好而熱烈。

Then, Chongqing Vpon Pharmaceutical Co., Ltd. Dr. Hu expained the quality testing, research and development technology, market prospects and so on. The perseverance of the scientific research was admirable.After the two experts discussed the details on the Halofuginone technology and "TS technology" .

最后，鑒于中澳企業(yè)和代表與我協(xié)會(huì )達成的國際推廣合作高度共識，澳大利亞阿爾法歐米茄生物科技公司和重慶威鵬藥業(yè)有限公司均與我協(xié)會(huì )簽署了戰略合作協(xié)議，為后期國際項目合作落地夯實(shí)了共識根基。同時(shí)，澳大利亞阿爾法歐米茄生物科技公司與我協(xié)會(huì )簽署了項目招商授權書(shū)。這標志著(zhù)澳大利亞中國西南部企業(yè)家協(xié)會(huì )的國際橋梁鏈接服務(wù)再次邁出前進(jìn)的腳步。重慶威鵬藥業(yè)董事長(cháng)林國躍先生和澳大利亞阿爾法歐米茄生物科技公司商業(yè)總監Ben Bootle先生均表示了對我協(xié)會(huì )平臺的職能和專(zhuān)業(yè)服務(wù)表示認可與支持，十分期待深度合作。協(xié)會(huì )執行會(huì )長(cháng)游尊偉先生對兩位的認可和支持表示真誠感謝，并表明他會(huì )代表澳大利亞中國西南部企業(yè)家協(xié)會(huì )積極落實(shí)合作共識。

Finally, in view of the high degree of consensus among the Chinese and Australian enterprises and representatives of the international promotion cooperation reached by the association, AlphaOmega BIOSCIENCE CORPORATION PTY LTD and Chongqing Vpon Pharmaceutical Co., Ltd. have signed a strategic cooperation agreement with our association to lay a solid foundation for the cooperation of the international project. At the same time, Australia Alpha Omega Biotechnology Company and the association signed the project investment authorization. This marked the pace of the international link service of the Australian Entrepreneurs Association of Southwestern China. Mr. Lin Guoyue, Chairman of Chongqing Vpon Pharmaceutical Co., Ltd.and Ben Bootle, Commercial Director of AlphaOmega BIOSCIENCE CORPORATION PTY LTD, have expressed their appreciation and support for the functions and professional services of our association platform. The executive director of the Association, Mr. You Zunwei, expressed the recognition and support of the two countries and showed that he would actively implement the consensus on behalf the Australian Entrepreneurs Association of Southwestern China.